FR2405298A1 - Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments - Google Patents

Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments

Info

Publication number
FR2405298A1
FR2405298A1 FR7702266A FR7702266A FR2405298A1 FR 2405298 A1 FR2405298 A1 FR 2405298A1 FR 7702266 A FR7702266 A FR 7702266A FR 7702266 A FR7702266 A FR 7702266A FR 2405298 A1 FR2405298 A1 FR 2405298A1
Authority
FR
France
Prior art keywords
escherichia coli
glyco
antiinflammatory
infections
protein isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7702266A
Other languages
English (en)
Other versions
FR2405298B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cassenne Laboratoires
Original Assignee
Cassenne Laboratoires
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassenne Laboratoires filed Critical Cassenne Laboratoires
Priority to FR7702266A priority Critical patent/FR2405298A1/fr
Publication of FR2405298A1 publication Critical patent/FR2405298A1/fr
Application granted granted Critical
Publication of FR2405298B1 publication Critical patent/FR2405298B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Nouvelles glycoprotéines hydrosolubles, caractérisées en ce qu'elles sont extraites de corps microbiens lysés d'Escherichia Coli et en ce qu'elles possèdent un poids moléculaire apparent égal ou supérieur à 300 000. Procédé de préparation et application à titre de médicaments de ces nouveaux produits.
FR7702266A 1977-01-27 1977-01-27 Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments Granted FR2405298A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7702266A FR2405298A1 (fr) 1977-01-27 1977-01-27 Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7702266A FR2405298A1 (fr) 1977-01-27 1977-01-27 Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments

Publications (2)

Publication Number Publication Date
FR2405298A1 true FR2405298A1 (fr) 1979-05-04
FR2405298B1 FR2405298B1 (fr) 1982-09-17

Family

ID=9185963

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7702266A Granted FR2405298A1 (fr) 1977-01-27 1977-01-27 Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments

Country Status (1)

Country Link
FR (1) FR2405298A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
EP0331821A1 (fr) * 1988-02-03 1989-09-13 Kureha Kagaku Kogyo Kabushiki Kaisha Agent anti-viral
FR2648351A1 (fr) * 1989-06-20 1990-12-21 Roussel Uclaf Utilisation de complexes glycoproteiques extraits de bacteries gram(-) pour la fabrication d'un medicament facilitant la cicatrisation de la peau et procede de preparation
WO1993016190A1 (fr) * 1992-02-14 1993-08-19 Laboratoires Om Sa Extrait de macromolecules bacteriennes, procede pour sa preparation et composition pharmaceutique contenant cet extrait

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
EP0089266A1 (fr) * 1982-03-09 1983-09-21 Pierre Fabre S.A. Procédé de préparation de protéoglycanes immunostimulants inducteurs d'interféron, protéoglycanes obtenus et médicament les contenant
EP0331821A1 (fr) * 1988-02-03 1989-09-13 Kureha Kagaku Kogyo Kabushiki Kaisha Agent anti-viral
FR2648351A1 (fr) * 1989-06-20 1990-12-21 Roussel Uclaf Utilisation de complexes glycoproteiques extraits de bacteries gram(-) pour la fabrication d'un medicament facilitant la cicatrisation de la peau et procede de preparation
EP0404660A2 (fr) * 1989-06-20 1990-12-27 Roussel-Uclaf Utilisation de complexes glycoprotéines extraits de bactéries gram (-) pour la fabrication d'un médicament facilitant la cicatrisation de la peau et procédé de préparation
EP0404660A3 (fr) * 1989-06-20 1991-12-04 Roussel-Uclaf Utilisation de complexes glycoprotéines extraits de bactéries gram (-) pour la fabrication d'un médicament facilitant la cicatrisation de la peau et procédé de préparation
WO1993016190A1 (fr) * 1992-02-14 1993-08-19 Laboratoires Om Sa Extrait de macromolecules bacteriennes, procede pour sa preparation et composition pharmaceutique contenant cet extrait
US5424287A (en) * 1992-02-14 1995-06-13 Laboratoires Om Sa Extract of bacterial macromolecules, a process for its preparation and a pharmaceutical composition containing the same

Also Published As

Publication number Publication date
FR2405298B1 (fr) 1982-09-17

Similar Documents

Publication Publication Date Title
CA2092533A1 (fr) Sequences des nucleotides encodant une proteine humaine ayant des proprietes de regulatrice de l'angiogenese
HUT43985A (en) Process for preparing vinyl phenol derivatives
EP0254289A3 (en) Agent for the treatment of arthrosis
DK0489860T3 (da) Fremgangsmåder og sammensætninger til heling af sår
EP0933995B8 (fr) Methode de traitement des lesions endotheliales
EP0229654A3 (fr) Traitement des dermatoses inflammatoires et infectieuses diffèrentes de l'acné et de la chute des cheveux
IE40860L (en) N- heterocyclylalkylbenzamides
NO975136D0 (no) Farmasöytisk blanding omfattende Lactobacillus plantarum og arginin
DK0942741T3 (da) Lektinpræparater og anvendelser deraf
FR2405298A1 (fr) Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments
AU458386B2 (en) Improvements in or relating tothe treatment of diseases ofthe skin and mucosa
FR2296428A1 (fr) Composition de proteines a usage dietetique et therapeutique chez le nourrisson, l'enfant et l'adulte
NO832089L (no) Fremgangsmaate ved fremstilling av en terapeutisk virksom metronidazolester
EP0106309A3 (fr) Extraits biologiquement actifs, procédé pour leur obtention, agents pharmaceutiques et cosmétiques les contenant et leur utilisation comme additifs pour des produits alimentaires et stimulants
FR2134292A1 (en) Interferon compsns - contg halo desoxyuridines rifamycine or rifampycine
CA2160082A1 (fr) Melange possedant des proprietes antitumeurs
GB2207604B (en) Pharmaceutical comprising a hydroxy halogenated diphenyl and a diamidine
McMillan et al. Tropical bacterial pyoderma in Vietnam: an improved therapeutic regimen
IE782383L (en) Monic acid derivatives
EP0668771A4 (fr) Traitement des maladies autoimmunes par induction d'une tolerance des cellules, des tissus et des organes.
ES8706665A1 (es) Procedimiento de preparar nuevas sales de acidos carboxilicos, terapeuticamente utiles
Hamilton A comparative study of local burn treatments
FR2346017A1 (fr) Composition therapeutique pour le traitement des affections du tractus gastro-intestinal
FI913531A0 (fi) Anvaendning av 1,2-bensopyronderivater till behandling av maligna tumoerer hos maenniskan.
HUT59608A (en) Pharamceutical cosmatical composition for treating venous diseases, soft-tissue bruises, strains, other flogistic processes and lag ulcer

Legal Events

Date Code Title Description
ST Notification of lapse